Lewis H. Titterton's most recent trade in Anixa Biosciences Inc was a trade of 2,000 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Jan. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 23 Jan 2025 | 2,000 | 932,334 (4%) | 0% | 2.9 | 5,820 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 23 Jan 2025 | 1,000 | 933,334 (4%) | 0% | 3 | 3,000 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.01 per share. | 22 Jan 2025 | 2,000 | 930,334 (4%) | 0% | 3.0 | 6,020 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.59 per share. | 21 Jan 2025 | 6,000 | 928,334 (4%) | 0% | 2.6 | 15,540 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 17 Jan 2025 | 10,000 | 922,334 (4%) | 0% | 2.6 | 25,700 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 22 Oct 2024 | 16,000 | 912,334 (4%) | 0% | 2.6 | 41,200 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2024 | 16,000 | 0 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 30 Jul 2024 | 21,646 | 890,754 (4%) | 0% | 3.1 | 66,237 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 30 Jul 2024 | 5,580 | 896,334 (4%) | 0% | 3.2 | 18,023 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.03 per share. | 25 Jul 2024 | 7,700 | 869,108 (4%) | 0% | 3.0 | 23,331 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.81 per share. | 25 Jul 2024 | 796 | 861,408 (4%) | 0% | 2.8 | 2,237 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 14 Jun 2024 | 4,000 | 860,612 (4%) | 0% | 2.7 | 10,720 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 13 Jun 2024 | 405 | 856,612 (4%) | 0% | 2.7 | 1,094 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 10 Jun 2024 | 7,102 | 856,207 (4%) | 0% | 2.7 | 18,891 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 10 Jun 2024 | 330 | 849,105 (4%) | 0% | 2.6 | 858 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 07 Jun 2024 | 10,738 | 848,775 (4%) | 0% | 2.5 | 27,060 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 09 Apr 2024 | 15,009 | 838,037 (4%) | 0% | 3.3 | 49,230 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2023 | 120,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 27 Jul 2023 | 120,000 | 894,070 (4%) | 0% | 2.6 | 309,000 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.55 per share. | 27 Jul 2023 | 87,042 | 807,028 (3%) | 0% | 3.5 | 308,999 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 40,000 | 0 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 29 Sep 2022 | 40,000 | 774,070 (3%) | 0% | 2.6 | 103,000 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Sep 2022 | 300,000 | 734,070 (3%) | 1% | 0 | Common Stock | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 24 Jun 2022 | 30,000 | 1,018,070 (4%) | 0% | 2.6 | 77,250 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 30,000 | 0 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 16,000 | 0 | - | - | Employee Stock Option | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 24 Jun 2022 | 16,000 | 1,034,070 (4%) | 0% | 2.6 | 41,200 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 26 Apr 2022 | 10,000 | 988,070 (4%) | 0% | 2.8 | 27,900 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 12 Jan 2022 | 5,000 | 978,070 (4%) | 0% | 3.3 | 16,400 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 11 Jan 2022 | 2,000 | 973,070 (4%) | 0% | 3.2 | 6,400 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 10 Jan 2022 | 6,000 | 971,070 (4%) | 0% | 3.1 | 18,480 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 07 Jan 2022 | 11,000 | 965,070 (4%) | 0% | 3.1 | 33,880 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 29 Oct 2021 | 18,244 | 954,070 (4%) | 0% | 4.8 | 86,841 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 4.21 per share. | 26 Jul 2021 | 30,000 | 935,826 (4%) | 0% | 4.2 | 126,300 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 4.07 per share. | 15 Jul 2021 | 10,000 | 905,826 (4%) | 0% | 4.1 | 40,700 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 15 Jul 2021 | 2,200 | 895,826 (4%) | 0% | 3.7 | 8,030 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.72 per share. | 14 Jul 2021 | 23,300 | 893,626 (4%) | 0% | 3.7 | 86,676 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 19 Apr 2021 | 5,000 | 870,326 (4%) | 0% | 4.0 | 19,950 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 25 Mar 2021 | 45,000 | 865,326 (4%) | 0% | 4.8 | 217,800 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2021 | 200,000 | 820,326 (3%) | 0% | 0 | Common Stock | |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 11 Sep 2020 | 40,000 | 1,020,326 (4%) | 0% | 2.1 | 83,200 | Common Stock |
| Anixa Biosciences Inc | Lewis H. Titterton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) |